From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q4 2017 call → NOWe need to determine if management describes a recent transition into an approved/specified/listed status within buyers' systems, such that future business can arrive without discrete selling events, and that this is new with most volume ahead. Scan the transcript for relevant statements. Key points: - Paychex partnership: "white label reseller type relationship" where Paychex can offer Bridge to their customers. This is a reseller/distribution agreement, not necessarily a buyer-side system where the company is inserted into a procurement pathway. It's a channel partnership, but each sale still requires selling to Paychex's customers. Not exactly "approved supplier list" in the sense of a buyer's internal system. Also, it's a partnership, not a status that makes purchases automatic. The company still needs to persuade each end customer. So not a clear YES. - SUNET in Sweden: "selected Canvas as a preferred supplier for their member schools." This is a preferred supplier arrangement. That could be a gateway where member schools can choose Canvas without going through a full procurement process. The transcript says "Already 12 universities in Sweden representing almost 80,000 students have signed up for Canvas." This suggests that the preferred supplier status is recent and that many schools have signed up, but it's not clear if this is a new status that will unlock future volume without discrete selling. The phrase "preferred supplier" is a form of being listed/approved. And it's recent (Q4 2017). The company says "This implementation will be one of our largest Moodle migrations in Europe to-date." But the key is whether management conveys that this access is new and that most volume is ahead. They mention that 12 universities have signed up, but they don't explicitly say that this is just the beginning and that future volume will come without selling. However, the concept of a preferred supplier for a network of schools means that those schools can adopt Canvas without a full RFP process, so it reduces friction. But is it "new enough that most of the volume it will unlock is still ahead"? The transcript says "Already 12 universities... have signed up" which implies some have, but it's not clear if that's a small fraction. Also, the context is that this is a recent selection (Q4). So it could be considered a gateway.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.